ACR Basic & Clinical Research Conference: Disrupting the Genetics of Rheumatology: The Role of Somatic Mutations in Health and Disease

ACR基础

• 批准号: 10540583
• 负责人: Kristine A. Kuhn
• 金额: $ 6万
• 依托单位: AMERICAN COLLEGE OF RHEUMATOLOGY
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-09-01 至 2027-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10540583
• 关键词: Advocacy; Affect; American; Arthritis; Basic Science; Biology; Characteristics; Clinical; Clinical Research; Clinical Services; Colorado; Communities; Degenerative polyarthritis; Department chair; Development; Discipline; Disease; Education; Epidemiology; Event; Evolution; Fostering; Genetic; Genome; Goals; Grant; Head; Health; Health Services Research; Healthcare; Human; Immunology; Immunotherapeutic agent; Investigation; Israel; Knowledge; Laboratories; Medical; Medical Research; Medical center; Medicine; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Oral; Pain; Participant; Patient Care; Patients; Persons; Physiology; Practice Management; Public Health; Public Health Schools; Research; Research Institute; Research Personnel; Research Training; Resources; Rheumatism; Rheumatology; Role; Schedule; Scientist; Somatic Mutation; Spondylarthritis; Time; Training; Translating; Translational Research; Underrepresented Minority; United States National Institutes of Health; Universities; chronic pain; clinical practice; college; coronavirus disease; cost; genetic epidemiology; improved; insight; interest; meetings; mid-career faculty; novel therapeutics; professor; programs; symposium; virtual

Project Summary-Abstract The American College of Rheumatology (ACR) has been a leader in the effort to facilitate the bidirectional exchange of cutting-edge scientific information between scientists and investigators in rheumatic diseases through its annual Basic and Clinical Research Conferences. The ACR has successfully hosted the conference as separate programs and as a combined basic science and clinical research program, as well as both in- person and virtually. Each program has been held in conjunction with ACR’s annual meeting, Convergence. The ACR annual meeting, ACR Convergence, attracts between 10,000 and 15,000 attendees each year and is the principal mechanism for providing a forum for the exchange of ideas about research, education, patient care, practice management and advocacy issues. Because the Basic and Clinical Research Conferences have been held in conjunction with ACR Convergence, typically as a pre-meeting event, ACR has been able to attract renown scientists and investigators who may otherwise not have attended. For 2022, the Basic and Clinical Research Conference will be held jointly to attract scientists and investigators from both the basic, clinical and translational research communities. The tentative title of the conference is Disrupting the Genetics of Rheumatology: The Role of Somatic Mutations in Health and Disease . This combined approach will focus on the role of somatic mutations in the development rheumatologic diseases. Clinical research sessions will focus on genetic epidemiology approaches for associating somatic mutations with disease. Basic research sessions will explore topics such as identification of the presence and functional role of somatic mutations. The conference organizers include Dr. Jill Norris, Professor and Chair of the Department of Epidemiology at the Colorado School of Public Health; Dr. Peter Grayson, Earl Stadtman Investigator at the NIAMS; Dr. Linda Hiraki, ACR Committee on Research Liaison, Clinician-Scientist in the Division of Rheumatology and Scientist in Genetics & Genome Biology at SickKids Research Institute; Dr. Iannis Adampopoulos, ACR Committee on Research Liaison, Director of the Arthritis Program and Head of Osteoimmunity Laboratory at the Beth Israel Deaconess Medical Center; and Dr. Kristine Kuhn, ACR Committee on Research Chair and Associate Professor of Medicine-Rheumatology at the University of Colorado and the Co-Director of the University of Colorado Program for Advancing Spondyloarthritis Treatment. The ACR Committee on Research focuses on research and research training in rheumatology and encourages clinical and health services research on the organization of medical and health care as they may affect patients with rheumatic diseases.

项目摘要提取 美国风湿病学院（ACR）一直是促进双向的领导者 风湿性疾病中的科学家与研究人员之间的尖端科学信息交流 通过其年度基本和临床研究会议。 ACR已成功主持了会议 作为单独的计划以及一项合并的基础科学和临床研究计划，以及两者 人，实际上。每个计划都与ACR的年度会议融合一起举行。 ACR年度会议，ACR融合，每年10,000至15,000名与会者的景点， 提供有关研究，教育，患者的思想交换论坛的主要机制 护理，实践管理和倡导问题。因为基本和临床研究会议有 与ACR收敛结合在一起，通常作为会议事件，ACR已经能够 吸引可能没有参加的著名科学家和调查人员。 2022年，基本和临床研究会议将共同举行，以吸引科学家和研究人员 来自基本，临床和翻译研究社区。会议的暂定标题是 破坏风湿病的遗传学：体细胞突变在健康和疾病中的作用。这 合并的方法将集中于体细胞突变在发育流变学疾病中的作用。 临床研究课程将集中于遗传流行病学方法，以关联体细胞突变 疾病。基础研究课程将探讨诸如识别存在和功能之类的主题 体细胞突变的作用。 会议组织者包括吉尔·诺里斯（Jill Norris）博士，教授兼流行病学系主席 科罗拉多州公共卫生学院； Niams的伯爵Stadtman调查员Peter Grayson博士；琳达博士 Hiraki，ACR研究联络委员会，风湿病学系临床医生和科学家临床医生 Sickkids研究所的遗传学和基因组生物学专业； ACR委员会Iannis Adampopoulos博士 研究联络人，关节炎计划主任兼贝丝以色列骨气免疫实验室的负责人 执事医疗中心； ACR研究主席兼助理委员会克里斯汀·库恩（Kristine Kuhn）博士 科罗拉多大学的医学教授 - 雷姆科学教授和大学联合主任 科罗拉多州推进脊椎关节炎治疗的计划。 ACR研究委员会的重点 风湿病学研究与研究培训，并鼓励有关临床和健康服务研究 组织和医疗保健的组织可能会影响风湿病患者。